又一种用于治疗皮肤感染的新型抗生素以及传染病专家为何是伪君子。 - Suppr

Suppr

超能文献

Another New Antibiotic for Skin Infections and Why Infectious Disease Specialists Are Hypocrites.

作者信息

Miller Loren G

机构信息

Division of Infectious Diseases and Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance.

David Geffen School of Medicine at the University of California, Los Angeles.

出版信息

Clin Infect Dis. 2019 Mar 19;68(7):1223-1224. doi: 10.1093/cid/ciy720.

DOI:10.1093/cid/ciy720

PMID:30137243

Abstract

摘要

相似文献

Another New Antibiotic for Skin Infections and Why Infectious Disease Specialists Are Hypocrites.又一种用于治疗皮肤感染的新型抗生素以及传染病专家为何是伪君子。

Clin Infect Dis. 2019 Mar 19;68(7):1223-1224. doi: 10.1093/cid/ciy720.

A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study.静脉注射后序贯口服多氟喹诺酮与万古霉素联合氨曲南治疗急性细菌性皮肤及皮肤结构感染的疗效和安全性比较：一项 3 期、多国、双盲、随机研究。

Clin Infect Dis. 2018 Aug 16;67(5):657-666. doi: 10.1093/cid/ciy165.

The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam.替加环素治疗皮肤及皮肤结构感染的疗效与安全性：两项与万古霉素-氨曲南对比的双盲3期研究结果

Clin Infect Dis. 2005 Sep 1;41 Suppl 5:S341-53. doi: 10.1086/431675.

Overview of tigecycline efficacy and safety in the treatment of complicated skin and skin structure infections - a European perspective.替加环素治疗复杂性皮肤及皮肤结构感染的疗效与安全性概述——欧洲视角

J Chemother. 2008 Oct;20 Suppl 1:20-7. doi: 10.1179/joc.2008.20.Supplement-1.20.

Efficacy and safety of tigecycline monotherapy compared with vancomycin-aztreonam in the treatment of complicated skin and skin structure infections in patients from India and Taiwan.替加环素单药治疗与万古霉素-氨曲南联合治疗用于治疗印度和中国台湾地区复杂性皮肤和皮肤软组织感染患者的疗效和安全性比较。

J Microbiol Immunol Infect. 2011 Apr;44(2):116-24. doi: 10.1016/j.jmii.2010.04.002. Epub 2011 Jan 15.

Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial.替加环素单药治疗与万古霉素联合氨曲南治疗复杂性皮肤及皮肤结构感染患者的疗效和安全性比较：一项3期随机双盲试验的结果

Int J Infect Dis. 2005 Sep;9(5):251-61. doi: 10.1016/j.ijid.2005.05.003.

Integrated safety summary of CANVAS 1 and 2 trials: Phase III, randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.CANVAS 1 和 2 试验的综合安全性总结：III 期、随机、双盲研究，评估头孢洛林酯治疗复杂性皮肤和皮肤结构感染患者。

J Antimicrob Chemother. 2010 Nov;65 Suppl 4:iv67-iv71. doi: 10.1093/jac/dkq256.

Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam.替加环素治疗皮肤及皮肤结构感染的安全性和有效性：与万古霉素-氨曲南的双盲3期对照研究结果

Antimicrob Agents Chemother. 2005 Nov;49(11):4658-66. doi: 10.1128/AAC.49.11.4658-4666.2005.

A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities.一项针对伴有全身炎症反应或基础合并症的复杂皮肤及软组织感染患者的III期随机对照非劣效性试验，比较每8小时使用600毫克头孢洛林酯与万古霉素加氨曲南的疗效。

J Antimicrob Chemother. 2016 Dec;71(12):3575-3584. doi: 10.1093/jac/dkw333. Epub 2016 Sep 1.

Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection.CANVAS1 和 2 综合分析：3 期、多中心、随机、双盲研究，评估头孢洛林与万古霉素加氨曲南治疗复杂性皮肤和皮肤结构感染的安全性和疗效。

Clin Infect Dis. 2010 Sep 15;51(6):641-50. doi: 10.1086/655827.

引用本文的文献

The Intersection of Antimicrobial Stewardship, the Pharmaceutical Industry, and the Federal Legislature.抗菌药物管理、制药行业与联邦立法的交叉点

Open Forum Infect Dis. 2022 Aug 5;9(8):ofac404. doi: 10.1093/ofid/ofac404. eCollection 2022 Aug.

It's about the patients: Practical antibiotic stewardship in outpatient settings in the United States.这关乎患者：美国门诊环境中的实用抗生素管理

Front Med (Lausanne). 2022 Jul 27;9:901980. doi: 10.3389/fmed.2022.901980. eCollection 2022.

Afabicin, a First-in-Class Antistaphylococcal Antibiotic, in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Clinical Noninferiority to Vancomycin/Linezolid.阿法沙星，一种首创的抗葡萄球菌抗生素，治疗急性细菌性皮肤和皮肤结构感染：临床非劣效性优于万古霉素/利奈唑胺。

Antimicrob Agents Chemother. 2020 Sep 21;64(10). doi: 10.1128/AAC.00250-20.

Multicenter Study of the Real-World Use of Ceftaroline versus Vancomycin for Acute Bacterial Skin and Skin Structure Infections.多中心研究头孢洛林酯与万古霉素治疗急性细菌性皮肤和皮肤结构感染的真实世界应用。

Antimicrob Agents Chemother. 2019 Oct 22;63(11). doi: 10.1128/AAC.01007-19. Print 2019 Nov.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验